|
LOC283267 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.525200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.434200E-01 |
| Normal-vs-Stage2 |
2.763600E-01 |
| Normal-vs-Stage3 |
2.332600E-01 |
| Normal-vs-Stage4 |
6.008800E-01 |
| Stage1-vs-Stage2 |
7.010400E-02 |
| Stage1-vs-Stage3 |
1.067560E-01 |
| Stage1-vs-Stage4 |
4.337800E-01 |
| Stage2-vs-Stage3 |
9.777200E-01 |
| Stage2-vs-Stage4 |
8.856800E-01 |
| Stage3-vs-Stage4 |
8.700200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.260800E-01 |
| Normal-vs-AfricanAmerican |
4.452800E-01 |
| Normal-vs-Asian |
3.689000E-01 |
| Caucasian-vs-AfricanAmerican |
3.082000E-01 |
| Caucasian-vs-Asian |
3.530200E-01 |
| AfricanAmerican-vs-Asian |
4.227600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.589000E-01 |
| Normal-vs-Female |
1.052370E-01 |
| Male-vs-Female |
3.757700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.575000E-01 |
| Normal-vs-Extreme_Weight |
7.735800E-02 |
| Normal-vs-Obese |
6.380800E-01 |
| Normal-vs-Extreme_Obese |
8.771400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.392820E-01 |
| Normal_Weight-vs-Obese |
8.115200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.937000E-01 |
| Extreme_Weight-vs-Obese |
7.891600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.684400E-01 |
| Obese-vs-Extreme_Obese |
7.324200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.956400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.056200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.837900E-02 |
| Normal-vs-Age(81-100Yrs) |
7.064800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.167600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.338330E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.791600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.180200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.151200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.617400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.923000E-01 |
| Normal-VS-Type2 PRCC |
5.076200E-02 |
| Normal-VS-KIRP CIMP |
5.196400E-03 |
| Normal-VS-Unclassified PRCC |
4.904400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.538300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.500500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.277200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.643900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.228000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.595900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.876600E-01 |
| Normal-vs-N1 |
8.311700E-02 |
| Normal-vs-N2 |
8.115000E-01 |
| N0-vs-N1 |
5.978000E-02 |
| N0-vs-N2 |
8.519200E-01 |
| N1-vs-N2 |
3.785600E-01 |
|
|
